CD79A and Paraproteinemia: In an older study, it was found that the median survival of patients with IgA/lambda paraproteinemia was apparently shorter than that of other subgroups [45], while in a different stuy it was demonstrated that patients who had two different lambda light chain have a poor prognosis [46].